The purpose of this booklet is to provide practical guidance for identifying pipeline compounds with a potential for sports-related abuse and for sharing this information with the World Anti-Doping Agency (WADA).<\/p>\n
The advice provided in this booklet represents current best practices and has been agreed with WADA. This includes template documents for Confidentiality Agreements and a Memorandum of Understanding to facilitate interactions between companies and WADA, which are based on several years of experience in collaboration between WADA and industry.<\/p>\n
This booklet also applies to compounds that fail to complete all drug development stages, and do not achieve commercial viability, since these fall into a less well-controlled \u201cgrey zone.\u201d While compounds that complete all stages of development
\nand are granted marketing authorization are highly visible, well documented, and
\nwell regulated, experience has shown that those for which development is
\ndiscontinued may provide substantial doping abuse potential while having low
\nvisibility and less control and oversight. Such compounds are particularly attractive
\nto \u201chigh-profile abusers\u201d because they are thought to be unknown, hence
\nundetectable, and are likely to be part of a tailor-made doping regimen, thus
\nconferring significant competitive advantage.<\/p>\n
To optimize the chances of adoption and implementation, any procedure developed
\nby a company should provide a balance between theoretical stringency and the day-to-day realities of the work in both WADA and the biotechnology and pharmaceutical
\nindustries. Thus, the intention is to provide a simple, intuitive and transparent
\nprocess that:<\/p>\n
The purpose of this booklet is to provide practical guidance for identifying pipeline compounds with a potential for sports-related abuse and for sharing this information with the World Anti-Doping Agency (WADA).<\/p>\n","protected":false},"featured_media":8732,"template":"","publication_type":[6],"topic":[66],"class_list":["post-13335","publications","type-publications","status-publish","has-post-thumbnail","hentry","publication_type-report","topic-anti-doping"],"acf":[],"yoast_head":"\n